Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Inflamm Res ; 54(5): 194-203, 2005 May.
Article in English | MEDLINE | ID: mdl-15953991

ABSTRACT

OBJECTIVE: Our aim was to study how different SERMs modulate the inflammatory responses induced by lipopolysaccharide (LPS) or unmethylated CpG-oligonucleotides in mouse and rat microglial cells. MATERIALS AND METHODS: Inflammatory responses of mouse N9 microglial cells and rat primary hippocampal microglia to lipopolysaccharide (LPS) exposure were recorded by the secretion of nitric oxide (NO) and cytokine IL-6 in two models where SERM was added either 24 h before LPS addition or simultaneously or even after the LPS exposure. The responses of 17beta-estradiol, tamoxifen, raloxifene and ICI 182.780 were compared. Responses were recorded by ELISA, Northern and EMSA assays. RESULTS: SERMs but not 17beta-estradiol induced a significant, concentration-dependent anti-inflammatory response both in rat primary microglial cells and in mouse N9 microglial cells. The response was observed both in NO and IL-6 secretion as well as in total IL-6 mRNA expression. We have recently observed that histone deacetylase (HDAC) inhibitors can potentiate the LPS-induced inflammatory response. Raloxifene and tamoxifen inhibited the potentiation of LPS response induced by trichostatin A, an HDAC inhibitor, in N9 microglia. A SERM-induced anti-inflammatory response was observed in acute models where SERM was added simultaneously or even up to 6 h later than LPS exposure. In contrast, the pretreatment of N9 microglia with tamoxifen or raloxifene for 30 h before LPS exposure did not provide any protection against the LPS response. We also observed that the raloxifene-induced protection in N9 microglia was connected to a decline of LPS-induced DNA binding activity of AP-1 but not that of NF-kappaB transcription factors. CONCLUSIONS: Our results show that tamoxifen, raloxifene and ICI 182.780 induce an anti-inflammatory response in acute models of mouse and rat microglial cells. It seems that this response is not estrogen receptor-mediated but, probably, is attributable to some SERM-induced modulation of LPS-activated pro-inflammatory signalling cascades.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Microglia/pathology , Selective Estrogen Receptor Modulators/pharmacology , Animals , Astrocytes/cytology , Blotting, Northern , Cell Proliferation , Cells, Cultured , CpG Islands , DNA/metabolism , Dose-Response Relationship, Drug , Down-Regulation , Enzyme-Linked Immunosorbent Assay , Estradiol/analogs & derivatives , Estradiol/metabolism , Estradiol/pharmacology , Fulvestrant , Hippocampus/cytology , Histone Deacetylase Inhibitors , Histone Deacetylases/metabolism , Humans , Interleukin-6/blood , Interleukin-6/metabolism , L-Lactate Dehydrogenase/metabolism , Lipopolysaccharides/metabolism , Mice , Microglia/metabolism , Nitric Oxide/metabolism , Oligonucleotides/metabolism , Protein Binding , RNA, Messenger/metabolism , Raloxifene Hydrochloride/pharmacology , Rats , Rats, Wistar , Tamoxifen/pharmacology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...